Our group has previously identified a family of sulfonimide and amide derivatives as selective and potent PPARα antagonists, displaying marked antiproliferative effects in the low micromolar range on several cancer cell lines (pancreatic, colorectal, and paraganglioma models) [25]. Here, PPARA is linked to cancer.